Brief: Granules India Gets US FDA Approval For ANDA Filed For Metoprolol Succinate ER Tablets
08/08/2023 06:58
Aug 8 (Reuters) - Granules India Ltd GRAN.NS :
* RECEIVED US FDA APPROVAL FOR ANDA FILED FOR METOPROLOL
SUCCINATE
ER TABLETS
* US FDA HAS APPROVED CO'S ABBREVIATED NEW DRUG APPLICATION
(ANDA)
FOR METOPROLOL SUCCINATE ER TABLETS 25/50/100/200 MG
* CO FILED TWO ANDAS FOR SAME PRODUCT WITH DIFFERENT
TECHNOLOGIES
* THIS IS SECOND ANDA APPROVAL FOR METOPROLOL SUCCINATE ER
TABLETS
Source text for Eikon: ID:nBSE4mYNL0
Further company coverage: GRAN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake